HISTORY


  • 06/2019Partnership with GEMDC

    InHealth launches major partnership with GEMDC (confidential partnership in development)

  • 05/2019Blumio & CardieX Present Data at IEEE

    Blumio & CardieX present successful results from Macquarie University trial @ IEEE

  • 05/2019CardieX & inHealth Partnership with Health160

    CardieX & inHealth sign MOU with major Chinese telemedicine platform Health160

  • 05/2019CardieX China Established

    CardieX establishes local operations in China with presence in Shanghai and Beijing

  • 04/2019New Oscar 2 Approved in China

    Oscar 2 with SphygmoCor Inside receives China FDA approval

  • 04/2019inHealth to use AtCor Technology in Landmark Trial

    inHealth to launch world's first trial cardiovascular program with AtCor's SphygmoCor technology

  • 03/2019New China & Product Strategies

    CardieX announces new strategies for next-generation product development and China market expansion

  • 03/2019Expansion of Bayer Contract

    AtCor Medical expands Bayer contract to provide clinical trial support for major multinational heart failure drug trial

  • 01/2019inHealth Partnership with Anthem

    inHealth launches major co-marketing partnership with second largest health insurer in US

  • 12/2018inHealth Partnership with Global Electronics Company

    inHealth signs LOI with major global electronics company

  • 12/2018CardieX & Blumio JDA

    CardieX signs JDA with Blumio for wearable BP sensor development

  • 12/2018Growth Capital Raised

    $5.5M successfully raised in oversubscribed fundraising round

  • 11/2018inHealth Partnership with Kaiser Permanente

    inHealth partners with largest managed care health provider in US for diabetes clinical study

  • 10/2018inHealth Acquisition

    Majority acquisition of Los Angeles-based leading telehealth services provider in US

  • 06/2018Growth Capital Raised

    ~5M capital raising to support new growth initiatives
    (with ~30% participation from Directors/C2 Ventures)

  • 05/2018New Corporate Identity: CardieX

    AtCor Medical changes name to CardieX - ASX:CDX.

  • 05/2018AtCor Announces Wearables Trial

    AtCor Medical announces wearable monitor trial in strategic partnerships with Blumio and Macquarie University

  • 03/2018Investment in Blumio

    Investment in innovative Bay Area startup focused on next-generation wearable BP sensor

  • 03/2017A New Way Forward

    New management, strategy, and Board transition to refocus on core technology and new markets

  • 03/2016New Oscar 2 Approved in US

    Oscar 2 with SphygmoCor Inside receives FDA clearance

  • 01/2015 CPT Code Approval in US

    AMA and CMS approved introduction of CPT code 93050 for arterial pressure waveform analysis

  • 01/2014SphygmoCor XCEL Approved in China

    China Food & Drug Administration (CFDA) approval granted for newest SphygmoCor system

  • 11/2012SphygmoCor XCEL Approved in US

    FDA clearance granted for newest SphygmoCor system

  • 07/2008SphygmoCor CvMS Gains CE Mark

    Second generation SphygmoCor system receives CE Mark

  • 08/2007SphygmoCor CvMS Approved in US

    FDA clearance granted for second generation SphygmoCor system

  • 11/2005 IPO on ASX

    AtCor Medical IPOs on ASX - ASX:ACG

  • 04/2004US Division Established

    AtCor Medical, Inc. formed in the US.

  • 2002SphygmoCor Mx Approval in US

    FDA clearance granted for first generation SphygmoCor system

  • 2000SphygmoCor Mx Gains CE Mark

    First generation SphygmoCor system receives CE Mark

  • 1996SphygmoCor Approval in Australia

    First generation SphygmoCor system receives TGA approval

  • 1994AtCor Medical is Born

    Company founded by Dr. Michael O'Rouke - international leader in the field of cardiovascular physiology and medicine